Competitive Generic Therapies: Off-Patent Drugs With 1 Source
✉ Email this page to a colleague
This table lists drugs which, despite having no patents or regulatory protections, have a limited number of active sources.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Strength |
---|---|---|---|---|---|---|---|---|---|---|
Lupin Ltd | ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE | abacavir sulfate; lamivudine; zidovudine | TABLET;ORAL | 202912-001 | Dec 5, 2013 | RX | No | Yes | EQ 300MG BASE;150MG;300MG | |
Mission Pharma | LITHOSTAT | acetohydroxamic acid | TABLET;ORAL | 018749-001 | May 31, 1983 | RX | Yes | Yes | 250MG | |
Bausch And Lomb | MIOCHOL-E | acetylcholine chloride | FOR SOLUTION;OPHTHALMIC | 020213-001 | Sep 22, 1993 | RX | Yes | Yes | 20MG/VIAL | |
Bausch | XERESE | acyclovir; hydrocortisone | CREAM;TOPICAL | 022436-001 | Jul 31, 2009 | RX | Yes | Yes | 5%;1% | |
Ge Healthcare | OPTISON | albumin human | INJECTABLE;INJECTION | 020899-001 | Dec 31, 1997 | RX | Yes | Yes | 10MG/ML | |
3m | AVAGARD | alcohol; chlorhexidine gluconate | SOLUTION;TOPICAL | 021074-001 | Jun 7, 2001 | OTC | Yes | Yes | 61%;1% | |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Strength |